See today's BioWorld
To read the full story, subscribe or sign in.

Gilead's Antiretroviral Emtriva Receives FDA Approval In HIV

July 3, 2003
By Aaron Lorenzo
HIV patients gained another treatment option yesterday as the FDA signed off on Emtriva, a once-daily capsule for HIV from Gilead Sciences Inc. (BioWorld Today)
BioWorld